Up‐regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF‐7 cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell Proliferation

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2184.2012.00820.xPMID 22452352PMCID PMC6495230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147

  2010cited by this paper
• VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers

  2010cited by this paper
• Annexin II represents metastatic potential in clear-cell renal cell carcinoma

  2009cited by this paper
• Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy.

  2009cited by this paper
• Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.

  2009cited by this paper
• Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection.

  2009cited by this paper
• Annexin II Overexpression Predicts Rapid Recurrence after Surgery in Pancreatic Cancer Patients Undergoing Gemcitabine-Adjuvant Chemotherapy

  2008cited by this paper
• Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.

  2008cited by this paper
• Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.

  2008cited by this paper
• Annexin II Overexpression Predicts Rapid Recurrence after Surgery in Pancreatic Cancer Patients Undergoing Gemcitabine-Adjuvant Chemotherapy

  2008cited by this paper
• Urokinase-Type Plasminogen Activator Stimulation of Monocyte Matrix Metalloproteinase-1 Production Is Mediated by Plasmin-Dependent Signaling through Annexin A2 and Inhibited by Inactive Plasmin1

  2007cited by this paper
• Involvement of CD147 in regulation of multidrug resistance to P‐gp substrate drugs and in vitro invasion in breast cancer cells

  2007cited by this paper
• Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells

  2007cited by this paper
• Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

  2007cited by this paper
• Up‐regulation of CD147 and matrix metalloproteinase‐2, ‐9 induced by P‐glycoprotein substrates in multidrug resistant breast cancer cells

  2007cited by this paper
• Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.

  2006cited by this paper
• Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.

  2006cited by this paper
• Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.

  2005cited by this paper
• Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells

  2005cited by this paper
• Annexin A2 binds to the localization signal in the 3′ untranslated region of c‐myc mRNA

  2005cited by this paper
• Role of the Protein Kinase C-&egr;–Raf-1–MEK-1/2–p44/42 MAPK Signaling Cascade in the Activation of Signal Transducers and Activators of Transcription 1 and 3 and Induction of Cyclooxygenase-2 After Ischemic Preconditioning

  2005cited by this paper
• Regulation of Annexin A2 by Reversible Glutathionylation*

  2004cited by this paper
• Matrix metalloproteinases in reproductive endocrinology.

  2004cited by this paper
• Annexin A2 Is a Novel RNA-binding Protein

  2004cited by this paper
• Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

  2004cited by this paper
• The Serine Protease Plasmin Triggers Expression of MCP-1 and CD40 in Human Primary Monocytes via Activation of p38 MAPK and Janus Kinase (JAK)/STAT Signaling Pathways*

  2002cited by this paper
• Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

  2002cited by this paper
• Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.

  2001cited by this paper
• Annexin II overexpression correlates with stromal tenascin‐C overexpression

  2001cited by this paper
• Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation

  1995cited by this paper
• PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint

  1993cited by this paper
• Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

  1993cited by this paper
• Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.

  1992cited by this paper
• Characterization of the human lipocortin-2-encoding multigene family: its structure suggests the existence of a short amino acid unit undergoing duplication.

  1990cited by this paper
• Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.

  1990cited by this paper
• Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

  1987cited by this paper

• Annexin A2-dependent extracellular vesicle proteome modulates pre-metastatic stromal fibroblast behavior in triple-negative breast cancer

  2026cites this paper
• Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia

  2026cites this paper
• Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies

  2025cites this paper
• The diagnosis and prognostic value and biological function of annexin A2 in hepatocellular carcinoma: a bioinformatic and experimental study.

  2025cites this paper
• Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer

  2024cites this paper
• The function and effect on prognosis of ANXA2 in gastric cancer peritoneal metastasis patients in cold region

  2024cites this paper
• Annexin A2: the feasibility of being a therapeutic target associated with cancer metastasis and drug resistance in cancer microenvironment

  2024cites this paper
• Label-based comparative proteomics of oral mucosal tissue to understand progression of precancerous lesions to oral squamous cell carcinoma

  2024cites this paper
• FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma

  2024cites this paper
• Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications

  2022cites this paper
• Annexin A2: The diversity of pathological effects in tumorigenesis and immune response

  2022cites this paper
• Advances in cancer treatment: a new therapeutic target, Annexin A2

  2021cites this paper
• Not So Dead Genes—Retrocopies as Regulators of Their Disease-Related Progenitors and Hosts

  2021cites this paper
• Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion

  2021cites this paper
• The Janus Nature of Nanohydroxyapatite in Tumor Progression

  2021cites this paper
• Proteomic Analysis Identifies Potential Markers for Chicken Primary Follicle Development

  2021cites this paper
• Defective membrane repair machinery impairs survival of invasive cancer cells

  2020cites this paper
• Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma

  2020cites this paper
• Long Noncoding RNAs Coregulated by Annexin A7 and JNK in Hepatocellular Carcinoma Cells Identified by Whole-Genome Expression Profiling

  2020cites this paper
• Deep Proteomic Deconvolution of Interferons and HBV Transfection Effects on a Hepatoblastoma Cell Line

  2020cites this paper
• Annexin A2–STAT3–Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma

  2020cites this paper
• Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism

  2019cites this paper
• Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.

  2019cites this paper
• ANXA2Tyr23 and FLNASer2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis.

  2019cites this paper
• LABEL-FREE CERVICOVAGINAL FLUID PROTEOME PROFILING REFLECTS THE CERVIX NEOPLASTIC TRANSFORMATION.

  2019cites this paper
• lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p

  2019cites this paper
• ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis

  2018cites this paper
• Targeting of embryonic annexin A2 expressed on ovarian and breast cancer by the novel monoclonal antibody 2448

  2018cites this paper
• Crosstalk in cancer resistance and metastasis.

  2018cites this paper
• Provisional chapter S 100 A 10 : A Key Regulator of Fibrinolysis

  2017cites this paper
• Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation

  2017cites this paper
• RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α.

  2017cites this paper
• Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells

  2017cites this paper
• Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT.

  2017cites this paper
• Annexin 2A sustains glioblastoma cell dissemination and proliferation

  2016cites this paper
• Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.

  2016cites this paper
• Annexin A2 Coordinates STAT3 to Regulate the Invasion and Migration of Colorectal Cancer Cells In Vitro

  2016cites this paper
• In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms

  2015cites this paper
• Under‐expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma

  2015cites this paper
• A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.

  2015cites this paper
• RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway

  2015influential citation
• Investigating the role of Annexin A2 in Epidermal Growth Factor (EGF) induced signalling in cancer

  2015cites this paper
• Annexin A 2 autoantibodies in thrombosis and autoimmune diseases

  2015cites this paper
• Annexin A2 autoantibodies in thrombosis and autoimmune diseases.

  2015cites this paper
• Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells

  2015cites this paper
• Association of annexin A2 with cancer development (Review).

  2015cites this paper
• Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression.

  2015cites this paper
• Characterization of annexin A2 in chicken follicle development: Evidence for its involvement in angiogenesis.

  2015cites this paper
• P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.

  2014cites this paper
• S100A10: A Key Regulator of Fibrinolysis

  2014cites this paper
• Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation

  2014cites this paper
• Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation

  2014cites this paper
• Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway

  2014cites this paper
• The secretome signature of colon cancer cell lines

  2013cites this paper
• Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.

  2013cites this paper
• Microcalcifications in breast cancer: Lessons from physiological mineralization.

  2013cites this paper
• Global characterization of signalling networks associated with tamoxifen resistance in breast cancer

  2013cites this paper
• miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts

  2013cites this paper
• ANXA2 regulates the behavior of SGC-7901 cells.

  2013cites this paper
• Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells

  2012cites this paper